Abstract:Using the Swedish Family-Cancer Database covering over 11.5 million individuals, estimated relative risks (RRs) for colorectal adenoma were using Poisson's regression. The RR of colorectal adenoma was found to be increased among first-degree relatives of patients with colorectal cancer (2.72; 95% confidence interval ¼ 2.46 -3.00) and among the offspring and siblings of patients with endometrial and prostate cancers. We also found an increased risk of colorectal adenoma for the offspring of individuals with sto… Show more
“…The use of registry based data restricted our ability to quantify the independent effects of several additional risk factors given the Queensland Cancer Registry does not record information on receipt and completion of systemic therapies [16], genetic conditions [30], microsatellite instability [31], family history [47], lifestyle [32,48], environmental exposures [49], and surveillance intensity [50]. In particular, we lacked information to determine what effect, if any, radiation treatment for the first cancer had on the risk of subsequent cancers.…”
While these population-based results do not incorporate all possible risk factors, they form an important foundation from which to further investigate the etiological causes that result in the development of MPCs among colorectal cancer survivors.
“…The use of registry based data restricted our ability to quantify the independent effects of several additional risk factors given the Queensland Cancer Registry does not record information on receipt and completion of systemic therapies [16], genetic conditions [30], microsatellite instability [31], family history [47], lifestyle [32,48], environmental exposures [49], and surveillance intensity [50]. In particular, we lacked information to determine what effect, if any, radiation treatment for the first cancer had on the risk of subsequent cancers.…”
While these population-based results do not incorporate all possible risk factors, they form an important foundation from which to further investigate the etiological causes that result in the development of MPCs among colorectal cancer survivors.
“…However, previous GWA studies mainly focused on patients with CRC, and it is not known whether the functional variants tagged by these SNPs act through increasing the risk of adenomas, carcinomas, or both. The familial risk of colorectal adenomas is estimated as similar to that of CRCs (Hiripi et al 2008), suggesting that some of the common genetic predisposition to CRC may be mediated through increased adenoma risk. Indeed, adenomas can be regarded as an intermediate phenotype between SNP and cancer (Carvajal-Carmona 2010), and under some plausible scenarios CRC predisposition polymorphisms might be associated more strongly with the risk of colorectal adenoma(s) than with CRC.…”
Several genome-wide association studies on colorectal cancer (CRC) have reported similar findings of a new susceptibility locus, 15q13.3. After that, a number of studies have reported that the rs4779584 and rs10318 polymorphisms at chromosome 15q13.3 have been implicated in CRC and colorectal adenoma (CRA) risk; however, these studies have yielded inconsistent results. To investigate this inconsistency, we performed a meta-analysis of 22 studies involving a total of 48,468 CRC cases, 4,189 CRA cases, and 85,105 controls for the two polymorphisms to evaluate its effect on genetic susceptibility for CRC/CRA. Potential sources of heterogeneity and publication bias were also systematically explored. Overall, the summary odds ratio (OR) of rs4779584-T variant for CRC was 1.13 (95 % CI 1.09-1.16, P < 10(-5)) and 1.15 (95 % CI 1.04-1.28, P = 0.006) for CRA. After stratified by ethnicity, significantly increased CRC risks were found for rs4779584 polymorphism among East Asians and Caucasians, while no significant associations were detected among African American and other ethnic populations. A meta-analysis of studies on the rs10318 polymorphism also showed significant overall association with CRC, yielding a per-allele OR of 1.13 (95 % CI 1.02-1.24, P = 0.02). In the subgroup analysis by ethnicity, significantly increased CRC risks were found in Caucasians; whereas no significant associations were found among East Asians and African Americans. This meta-analysis demonstrated that the rs4779584 and rs10318 polymorphism at 15q13.3 is a risk factor associated with increased CRC/CRA susceptibility, but these associations vary in different ethnic populations.
“…However, all these studies have focused on patients with CRC, and it is not known whether the functional variants tagged by these SNPs act through increasing the risk of adenomas, carcinomas or both. The familial risk of colorectal adenomas is estimated as similar to that of CRCs 9 , suggesting that some of the common genetic predisposition to CRC may be mediated through increased adenoma risk. Indeed, adenomas can be regarded as an intermediate phenotype between SNP and cancer 10 , and under some plausible scenarios, CRC predisposition polymorphisms might be more strongly associated with the risk of colorectal adenoma(s) than with CRC.…”
Several single nucleotide polymorphisms (SNPs) have been associated with colorectal cancer (CRC) susceptibility. Most CRCs arise from adenomas, and SNPs might therefore affect predisposition to CRC by increasing adenoma risk. We found that 8 of 18 known CRC-associated SNPs (rs10936599, rs6983267, rs10795668, rs3802842, rs4444235, rs1957636, rs4939827, and rs961253) were over-represented in CRC-free patients with adenomas, compared with controls. Ten other CRC-associated SNPs (rs6691170, rs6687758, rs16892766, rs7136702, rs11169552, rs4779584, rs9929218, rs10411210, rs4813802, and rs4925386) were not significantly associated with adenoma risk. Genetic susceptibility to CRC in the general population is likely to be mediated in part by predisposition to adenomas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.